Skip to main content
. 2018 Jul;6(13):263. doi: 10.21037/atm.2018.03.34

Table 5. Comparisons to 2011.

Patients cohorts (N = patients per period) SAR, % (95% CI) CCR, % (95% CI) ADR, % (95% CI) CR, % (95% CI)
2011 2013 2015 2011 2013 2015 2011 2013 2015 2011 2013 2015
A (N=617, 1,016, 1,213) 86.5 (83.8–89.2) 89.7 (87.8–91.5) 93.0 (91.6–94.4) 0.3 (0.0–1.2) 0.1 (0.0–0.5) 0.1 (0.0–0.5)
B (N=604, 999, 1,207) 87.6 (85–90.2) 90.2 (88.3–92.0) 93.1 (91.7–94.6) 96.4 (94.9–97.9) 94.8 (93.4–96.2) 98.1 (97.3–98.9) 0.3 (0.0–1.2) 0.1 (0.0–0.6) 0.1 (0.0–0.5)
C {N=234, 262 [525], 415 [722]} 88.5 (84.4–92.6) 93.5 (90.5–96.5) 95.9 (94–97.8) 98.3 (96.6–100) 96.6 [97.5] (94.4–98.8) [(96.2–98.9)] 98.6 [98.2] (97.4–99.7) [(97.2–99.2)] 35.0 (28.9–41.1) 27.1 [33.3] (21.7–32.5) [(29.3–37.4)] 27 [31] (22.7–31.3) [(27.7–34.4)] 0.9 (0.1–3.1) 0.0 (0.0–1.4) 0.0 (0.0–0.9)

Data in square brackets represent numbers including colorectal cancer (CRC) surveillance patients to match 2011 cohort C. N, number of colonoscopies; SAR, sedation administration rate; CI, confidence interval; CCR, colonoscopy completion rate; ADR, adenoma detection rate; CR, early complications rate.